» Articles » PMID: 7717777

The Whipple Resection for Cancer in U.S. Department of Veterans Affairs Hospitals

Overview
Journal Ann Surg
Specialty General Surgery
Date 1995 Mar 1
PMID 7717777
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The authors compiled the results after Whipple resection for cancer from a large U.S. national hospital system.

Methods: Computerized hospital and death benefits records for patients treated with Whipple resection for cancer from 1987 to 1991 in U.S. Department of Veterans Affairs hospitals were analyzed, excluding lymphomas and neuroendocrine tumors. Institutional tumor registrar reports allowed TNM staging in 45% of these cancers.

Results: Whipple resections were performed in 252 patients with pancreatic cancer and 117 with other periampullary cancers. Complications occurred in 37%, and 30-day operative mortality was 8%. Postoperative sepsis was associated with a higher operative mortality rate. In patients with staged tumors, 5-year survivors were found only in those without lymph node involvement.

Conclusions: Whipple resection can cure cancer in or near the head of the pancreas when lymph nodes are not invaded by tumor. Complications occur in nearly 40% of patients, whereas operative mortality rate is related to the average age of the patient population.

Citing Articles

Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.

Kuo Y, Kou H, Hsu C, Lo C, Hwang T Int J Mol Sci. 2023; 24(8).

PMID: 37108495 PMC: 10138402. DOI: 10.3390/ijms24087331.


Domino Reconstruction of the Portal Vein Using the External Iliac Vein and an ePTFE Graft in Pancreatic Surgery.

Yoshioka M, Uchinami H, Watanabe G, Iida M, Nakagawa Y, Miyazawa H J Gastrointest Surg. 2017; 21(8):1278-1286.

PMID: 28378316 DOI: 10.1007/s11605-017-3413-2.


Prosthetic graft for superior mesenteric-portal vein reconstruction in pancreaticoduodenectomy: a retrospective, multicenter study.

Liao K, Wang H, Chen Q, Wu Z, Zhang L J Gastrointest Surg. 2014; 18(8):1452-61.

PMID: 24916585 DOI: 10.1007/s11605-014-2549-6.


A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.

Lewis R, Drebin J, Callery M, Fraker D, Kent T, Gates J HPB (Oxford). 2012; 15(1):49-60.

PMID: 23216779 PMC: 3533712. DOI: 10.1111/j.1477-2574.2012.00571.x.


Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma.

Chakravarty K, Hsu J, Liu K, Yeh C, Yeh T, Hwang T World J Gastroenterol. 2010; 16(8):997-1002.

PMID: 20180240 PMC: 2828606. DOI: 10.3748/wjg.v16.i8.997.


References
1.
Crist D, Cameron J . Current status of pancreaticoduodenectomy for periampullary carcinoma. Hepatogastroenterology. 1989; 36(6):478-85. View

2.
BAUMEL H, Huguier M, Manderscheid J, Fabre J, Houry S, Fagot H . Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994; 81(1):102-7. DOI: 10.1002/bjs.1800810138. View

3.
Swope T, Wade T, Neuberger T, Virgo K, Johnson F . A reappraisal of total pancreatectomy for pancreatic cancer: results from U.S. Veterans Affairs hospitals, 1987-1991. Am J Surg. 1994; 168(6):582-5; discussion 585-6. DOI: 10.1016/s0002-9610(05)80126-6. View

4.
BRAASCH J, Deziel D, Rossi R, WATKINS Jr E, Winter P . Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg. 1986; 204(4):411-8. PMC: 1251310. DOI: 10.1097/00000658-198610000-00009. View

5.
WHIPPLE A . Pancreaticoduodenectomy for Islet Carcinoma : A Five-Year Follow-Up. Ann Surg. 1945; 121(6):847-52. PMC: 1618156. DOI: 10.1097/00000658-194506000-00008. View